Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Ploss

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Mbio|July 12, 2023
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
Nature Communications|July 27, 2017
Long-term hepatitis B infection in a scalable hepatic co-culture systemBenjamin Y Winer, Tiffany S Huang, Eitan Pludwinski, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Nature Communications|November 30, 2018
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responsesFlorian Douam, Carly G K Ziegler, Gabriela Hrebikova, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
The Journal of Infectious Diseases|May 8, 2025
Characterization of serotype-specific Dengue virus T cell inhibitionJinhua Xiang, James H McLinden, Qing Chang, et al.
Journal of Hepatology|April 11, 2017
Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapyElham Shirvani-Dastgerdi, Benjamin Y Winer, Toni Celià-Terrassa, et al.
The Journal of Experimental Medicine|June 3, 2009
Priming of protective T cell responses against virus-induced tumors in mice with human immune system componentsTill Strowig, Cagan Gurer, Alexander Ploss, et al.
Journal of Virology|September 3, 2025
Assessment of hepatitis C virus permissiveness in iteratively genetically humanized miceMichael P Schwoerer, Sebastian Carver, Thomas R Cafiero, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2006
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitroBrett D Lindenbach, Philip Meuleman, Alexander Ploss, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Mbio|July 12, 2023
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
Nature Communications|July 27, 2017
Long-term hepatitis B infection in a scalable hepatic co-culture systemBenjamin Y Winer, Tiffany S Huang, Eitan Pludwinski, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Nature Communications|November 30, 2018
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responsesFlorian Douam, Carly G K Ziegler, Gabriela Hrebikova, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
The Journal of Infectious Diseases|May 8, 2025
Characterization of serotype-specific Dengue virus T cell inhibitionJinhua Xiang, James H McLinden, Qing Chang, et al.
Journal of Hepatology|April 11, 2017
Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapyElham Shirvani-Dastgerdi, Benjamin Y Winer, Toni Celià-Terrassa, et al.
The Journal of Experimental Medicine|June 3, 2009
Priming of protective T cell responses against virus-induced tumors in mice with human immune system componentsTill Strowig, Cagan Gurer, Alexander Ploss, et al.
Journal of Virology|September 3, 2025
Assessment of hepatitis C virus permissiveness in iteratively genetically humanized miceMichael P Schwoerer, Sebastian Carver, Thomas R Cafiero, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2006
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitroBrett D Lindenbach, Philip Meuleman, Alexander Ploss, et al.
Pageof 17